• Western blot analysis of lysates from HCT116 cells, primary antibody was diluted at 1:1000, 4°C over night

Anti-NEUROD4 antibody (30-110 aa) (STJ191064)

SKU:
STJ191064

Current Stock:
Host: Rabbit
Applications: WB/ELISA
Reactivity: Human/Mouse
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-Neurogenic differentiation factor 4 (30-110 aa) is suitable for use in Western Blot and ELISA research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: Liquid in PBS containing 50% Glycerol and 0.02% Sodium Azide.
Purification: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Concentration: 1 mg/mL
Dilution Range: WB 1:500-2000
ELISA 1:5000-20000
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: NEUROD4
Gene ID: 58158
Uniprot ID: NDF4_HUMAN
Immunogen Region: 30-110 aa
Specificity: NDF4 Polyclonal Antibody detects endogenous levels of protein.
Immunogen: Synthesized peptide derived from the human protein at the amino acid range 30-110
Function Probably acts as a transcriptional activator. Mediates neuronal differentiation. Required for the regulation of amacrine cell fate specification in the retina.
Protein Name Neurogenic Differentiation Factor 4
Neurod4
Class A Basic Helix-Loop-Helix Protein 4
Bhlha4
Protein Atonal Homolog 3
Ath-3
Atoh3
Cellular Localisation Nucleus
Alternative Antibody Names Anti-Neurogenic Differentiation Factor 4 antibody
Anti-Neurod4 antibody
Anti-Class A Basic Helix-Loop-Helix Protein 4 antibody
Anti-Bhlha4 antibody
Anti-Protein Atonal Homolog 3 antibody
Anti-Ath-3 antibody
Anti-Atoh3 antibody
Anti-NEUROD4 antibody
Anti-ATH3 antibody
Anti-ATOH3 antibody
Anti-BHLHA4 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance